Read + Share
Amedeo Smart
Independent Medical Education
Skinner J, Kayentao K, Ongoiba A, Healy SA, et al. Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial. Nat Med 2025 Jun 3. doi: 10.1038/s41591-025-03739.PMID: 40461818
Email
LinkedIn
Privacy Policy